» Articles » PMID: 12488434

The Forkhead Transcription Factor Foxo1 Links Insulin Signaling to Pdx1 Regulation of Pancreatic Beta Cell Growth

Overview
Journal J Clin Invest
Specialty General Medicine
Date 2002 Dec 19
PMID 12488434
Citations 261
Authors
Affiliations
Soon will be listed here.
Abstract

Diabetes is caused by an absolute (type 1) or relative (type 2) deficiency of insulin-producing beta cells. The mechanisms governing replication of terminally differentiated beta cells and neogenesis from progenitor cells are unclear. Mice lacking insulin receptor substrate-2 (Irs2) develop beta cell failure, suggesting that insulin signaling is required to maintain an adequate beta cell mass. We report that haploinsufficiency for the forkhead transcription factor Foxo1 reverses beta cell failure in Irs2(-/-) mice through partial restoration of beta cell proliferation and increased expression of the pancreatic transcription factor pancreas/duodenum homeobox gene-1 (Pdx1). Foxo1 and Pdx1 exhibit mutually exclusive patterns of nuclear localization in beta cells, and constitutive nuclear expression of a mutant Foxo1 is associated with lack of Pdx1 expression. We show that Foxo1 acts as a repressor of Foxa2-dependent (Hnf-3beta-dependent) expression from the Pdx1 promoter. We propose that insulin/IGFs regulate beta cell proliferation by relieving Foxo1 inhibition of Pdx1 expression in a subset of cells embedded within pancreatic ducts.

Citing Articles

Tackling exosome and nuclear receptor interaction: an emerging paradigm in the treatment of chronic diseases.

Aswani B, Hegde M, Vishwa R, AlQahtani M, Abbas M, Almubarak H Mil Med Res. 2024; 11(1):67.

PMID: 39327610 PMC: 11426102. DOI: 10.1186/s40779-024-00564-1.


FoxO1 as a tissue-specific therapeutic target for type 2 diabetes.

Teaney N, Cyr N Front Endocrinol (Lausanne). 2023; 14:1286838.

PMID: 37941908 PMC: 10629996. DOI: 10.3389/fendo.2023.1286838.


Protective effects of curcumin on desipramine-induced islet β-cell damage via AKAP150/PKA/PP2B complex.

Hu M, Cai J, He Y, Chen K, Hao F, Kang J Acta Pharmacol Sin. 2023; 45(2):327-338.

PMID: 37845344 PMC: 10789796. DOI: 10.1038/s41401-023-01176-6.


Noncanonical CDK4 signaling rescues diabetes in a mouse model by promoting β cell differentiation.

Stamateris R, Landa-Galvan H, Sharma R, Darko C, Redmond D, Rane S J Clin Invest. 2023; 133(18).

PMID: 37712417 PMC: 10503800. DOI: 10.1172/JCI166490.


Regeneration of Pancreatic Beta Cells by Modulation of Molecular Targets Using Plant-Derived Compounds: Pharmacological Mechanisms and Clinical Potential.

Kimani C, Reuter H, Kotze S, Muller C Curr Issues Mol Biol. 2023; 45(8):6216-6245.

PMID: 37623211 PMC: 10453321. DOI: 10.3390/cimb45080392.


References
1.
Saltiel A, Kahn C . Insulin signalling and the regulation of glucose and lipid metabolism. Nature. 2001; 414(6865):799-806. DOI: 10.1038/414799a. View

2.
Withers D, Burks D, Towery H, Altamuro S, Flint C, White M . Irs-2 coordinates Igf-1 receptor-mediated beta-cell development and peripheral insulin signalling. Nat Genet. 1999; 23(1):32-40. DOI: 10.1038/12631. View

3.
Kim S, Selleri L, Lee J, Zhang A, Gu X, Jacobs Y . Pbx1 inactivation disrupts pancreas development and in Ipf1-deficient mice promotes diabetes mellitus. Nat Genet. 2002; 30(4):430-5. DOI: 10.1038/ng860. View

4.
Gu G, Dubauskaite J, Melton D . Direct evidence for the pancreatic lineage: NGN3+ cells are islet progenitors and are distinct from duct progenitors. Development. 2002; 129(10):2447-57. DOI: 10.1242/dev.129.10.2447. View

5.
Kulkarni R, Holzenberger M, Shih D, Ozcan U, Stoffel M, Magnuson M . beta-cell-specific deletion of the Igf1 receptor leads to hyperinsulinemia and glucose intolerance but does not alter beta-cell mass. Nat Genet. 2002; 31(1):111-5. DOI: 10.1038/ng872. View